See more : Exmar NV (0EEV.L) Income Statement Analysis – Financial Results
Complete financial analysis of Apollo Medical Holdings, Inc. (AMEH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Apollo Medical Holdings, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Xinjiang Machinery Research Institute Co., Ltd. (300159.SZ) Income Statement Analysis – Financial Results
- Blue Energy Limited (BLU.AX) Income Statement Analysis – Financial Results
- Australian Oilseeds Holdings Limited Ordinary Shares (COOT) Income Statement Analysis – Financial Results
- Austin Engineering Limited (ANG.AX) Income Statement Analysis – Financial Results
- WH Smith PLC (SMWH.L) Income Statement Analysis – Financial Results
Apollo Medical Holdings, Inc. (AMEH)
About Apollo Medical Holdings, Inc.
Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was founded in 1994 and is headquartered in Alhambra, California.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.14B | 773.92M | 370.25M | 560.62M | 519.91M | 356.36M | 57.43M | 44.05M | 32.99M | 10.48M | 7.78M | 5.11M | 3.90M | 2.44M | 1.06M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 944.69M | 596.14M | 348.54M | 467.81M | 361.13M | 273.45M | 48.74M | 34.00M | 22.07M | 9.08M | 6.32M | 4.13M | 3.31M | 1.81M | 1.05M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 199.48M | 177.77M | 21.71M | 92.81M | 158.78M | 82.90M | 8.69M | 10.05M | 10.92M | 1.41M | 1.46M | 978.41K | 581.86K | 627.51K | 11.25K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 17.43% | 22.97% | 5.86% | 16.56% | 30.54% | 23.26% | 15.14% | 22.81% | 33.11% | 13.43% | 18.77% | 19.14% | 14.93% | 25.70% | 1.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 77.67M | 62.08M | 15.59M | 41.48M | 43.35M | 26.25M | 18.58M | 16.96M | 11.28M | 5.29M | 3.52M | 1.38M | 566.65K | 694.32K | 827.29K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 77.67M | 62.08M | 15.59M | 41.48M | 43.35M | 26.25M | 18.58M | 16.96M | 11.28M | 5.29M | 3.52M | 1.38M | 566.65K | 694.32K | 827.29K | 36.65K | 27.48K | 13.34K | 10.09K | 7.80K |
| Other Expenses | 3.94M | -3.75M | 7.69M | 3.03M | 1.62M | 168.10K | 14.70K | 239.06K | 3.03K | 49.70K | -37.25K | 2.84K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 95.21M | 79.59M | 15.62M | 58.40M | 66.55M | 45.32M | 19.23M | 17.31M | 11.62M | 5.32M | 3.54M | 1.39M | 577.85K | 730.02K | 847.07K | 36.65K | 27.48K | 13.34K | 10.09K | 7.80K |
| Cost & Expenses | 1.04B | 675.74M | 364.16M | 526.20M | 427.68M | 318.78M | 67.96M | 51.31M | 33.68M | 14.39M | 9.85M | 5.52M | 3.89M | 2.54M | 1.89M | 36.65K | 27.48K | 13.34K | 10.09K | 7.80K |
| Interest Income | 1.98M | 1.57M | 405.00K | 2.02M | 1.26M | 1.02M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 7.92M | 5.39M | 2.53M | 4.73M | 561.00K | 79.69K | 82.91K | 542.30K | 1.33M | 679.18K | 930.18K | 304.03K | 126.43K | 53.13K | 55.20K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 29.09M | 11.03M | 25.93M | 18.43M | 19.30M | 19.08M | 351.40K | 351.40K | 334.43K | 31.36K | 20.92K | 12.59K | 11.20K | 35.70K | 19.78K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | 133.35M | 111.40M | 40.27M | 50.85M | 106.29M | 56.72M | -9.88M | -6.68M | -356.87K | -3.83M | -2.09M | -397.90K | 15.21K | -66.81K | -816.04K | -36.65K | -27.48K | -13.34K | -10.09K | -7.80K |
| EBITDA Ratio | 11.65% | 14.39% | 10.88% | 9.07% | 20.44% | 15.92% | -17.20% | -15.16% | -1.08% | -36.52% | -26.94% | -7.79% | 0.39% | -2.74% | -77.18% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | 104.27M | 98.18M | 6.09M | 32.42M | 88.43M | 35.15M | -10.54M | -7.27M | -694.33K | -3.91M | -2.08M | -413.34K | 4.02K | -102.52K | -835.82K | -36.65K | -27.48K | -13.34K | -10.09K | -7.80K |
| Operating Income Ratio | 9.11% | 12.69% | 1.64% | 5.78% | 17.01% | 9.86% | -18.35% | -16.50% | -2.10% | -37.29% | -26.73% | -8.09% | 0.10% | -4.20% | -79.05% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -17.65M | -20.43M | 2.78M | -8.57M | -9.60M | 14.57M | 1.81M | -978.30K | -489.83K | -629.48K | -6.82M | -301.19K | -158.75K | -92.77K | -55.20K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 86.62M | 77.75M | 8.87M | 25.84M | 82.63M | 49.71M | -8.73M | -8.24M | -1.18M | -4.54M | -8.90M | -714.53K | -154.73K | -195.28K | -891.02K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | 7.57% | 10.05% | 2.40% | 4.61% | 15.89% | 13.95% | -15.20% | -18.72% | -3.59% | -43.30% | -114.45% | -13.98% | -3.97% | -8.00% | -84.27% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 40.88M | 31.69M | 9.18M | 8.17M | 22.36M | 3.89M | -47.50K | -71.04K | 163.79K | 19.51K | 4.80K | 5.82K | 1.60K | 800.00 | 800.00 | 36.65K | 27.48K | 13.34K | 10.09K | 7.80K |
| Net Income | 45.17M | 68.92M | -23.75M | 14.12M | 10.84M | 25.80M | -8.97M | -9.34M | -1.80M | -5.02M | -8.90M | -720.35K | -156.33K | -196.08K | -891.82K | -36.65K | -27.48K | -13.34K | -10.09K | -7.80K |
| Net Income Ratio | 3.95% | 8.91% | -6.42% | 2.52% | 2.08% | 7.24% | -15.62% | -21.21% | -5.46% | -47.88% | -114.51% | -14.09% | -4.01% | -8.03% | -84.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 1.00 | 1.57 | -0.65 | 0.41 | 0.33 | 0.80 | -1.49 | -1.59 | -0.37 | -1.07 | -2.56 | -0.25 | -0.06 | -0.07 | -0.37 | -0.12 | -1.57 | -0.76 | -0.58 | -0.45 |
| EPS Diluted | 0.99 | 1.52 | -0.63 | 0.39 | 0.29 | 0.80 | -1.49 | -1.59 | -0.37 | -1.07 | -2.56 | -0.25 | -0.06 | -0.07 | -0.37 | -0.12 | -1.57 | -0.76 | -0.58 | -0.45 |
| Weighted Avg Shares Out | 44.97M | 43.83M | 36.53M | 34.71M | 32.89M | 32.30M | 6.03M | 5.88M | 4.86M | 4.70M | 3.48M | 2.93M | 2.75M | 2.65M | 2.40M | 299.70K | 17.51K | 17.51K | 17.51K | 17.51K |
| Weighted Avg Shares Out (Dil) | 45.60M | 43.83M | 37.45M | 36.40M | 37.91M | 32.30M | 6.03M | 5.88M | 4.86M | 4.70M | 3.48M | 2.93M | 2.75M | 2.65M | 2.40M | 299.70K | 17.51K | 17.51K | 17.51K | 17.51K |
Head-To-Head Survey: Roma Green Finance (NASDAQ:ROMA) & Astrana Health (NASDAQ:ASTH)
Roma Green Finance (NASDAQ:ROMA – Get Free Report) and Astrana Health (NASDAQ:ASTH – Get Free Report) are both finance companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, profitability,...
The 3 Most Popular Stocks Owned by Congress in Q1
Sometimes, the best trading advice can come from a list of stocks owned by Congress. If they are buying, you may want to look into it.
Apollo Medical Holdings, Inc. (AMEH) Soars 7.6%: Is Further Upside Left in the Stock?
Apollo Medical Holdings, Inc. (AMEH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Apollo Medical Holdings, Inc. Becomes Astrana Health, Inc.
ALHAMBRA, Calif. , Feb. 22, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc.("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all,...
Apollo Medical Holdings, Inc. (AMEH) Reports Next Week: Wall Street Expects Earnings Growth
Apollo Medical Holdings, Inc. (AMEH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ELV or AMEH: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical Services sector have probably already heard of Elevance Health (ELV) and Apollo Medical Holdings, Inc. (AMEH). But which of these two companies is the best option for those looking for undervalued stocks?
Apollo Medical Holdings, Inc. Schedules 2023 Fourth Quarter and Full Year Financial Results Release and Conference Call
ALHAMBRA, Calif. , Jan. 31, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to...
ApolloMed and BASS Medical Group to Forge a Value-Based Healthcare Partnership
ALHAMBRA, Calif. , Jan. 29, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc.("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to...
Apollo Medical Holdings, Inc. Announces Leadership Transitions
ALHAMBRA, Calif. , Jan. 24, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading provider-centric, technology-powered healthcare company which enables providers to deliver accessible, high-quality, and high-value...
Apollo Medical Holdings, Inc. Announces Planned Corporate Rebrand as Astrana Health
ALHAMBRA, Calif. , Jan. 24, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading provider-centric, technology-powered healthcare company which enables providers to deliver accessible, high-quality, and high-value...
Source: https://incomestatements.info
Category: Stock Reports